scieee Science in your language
[en] (orig)

TRPC6 channels are required for proliferation, migration and invasion of breast cancer cell lines by modulation of Orai1 and Orai3 surface exposure

Abstract

Transient receptor potential channels convey signaling information from a number of stimuli to a wide variety of cellular functions, mainly by inducing changes in cytosolic Ca2+ concentration. Different members of the TRPC, TRPM and TRPV subfamilies have been reported to play a role in tumorigenesis. Here we show that the estrogen receptor positive and triple negative breast cancer cell lines, MCF7 and MDA-MB-231, respectively, exhibit enhanced expression of the TRPC6 channel as compared to the non-tumoral MCF10A cell line. In vitro TRPC6 knockdown using shRNA impaired MCF7 and MDA-MB-231 cell proliferation, migration and invasion detected by BrdU incorporation, wound healing and Boyden chamber assays, respectively. Using RNAi-mediated TRPC6 silencing as well as overexpression of the pore-dead dominant-negative TRPC6 mutant we have found that TRPC6 plays a relevant role in the activation of store-operated Ca2+ entry in the breast cancer cell lines but not in non-tumoral breast cells. Finally, we have found that TRPC6 interacts with Orai1 and Orai3 in MCF7 and MDA-MB-231 cells and is required for the translocation of Orai1 and Orai3 to the plasma membrane in MDA-MB-231 and MCF7 cells, respectively, upon Ca2+ store depletion. These findings introduce a novel mechanism for the modulation of Ca2+ influx and the development of different cancer hallmarks in breast cancer cells.

Read accessible full text

TRPC6 channels are required for proliferation, migration and invasion of breast cancer cell lines by modulation of Orai1 and Orai3 surface exposure

Author: Jardín, Isaac; Diez Bello, Raquel; Lopez, Jose J.; Redondo, Pedro C.; Salido, Gines M.; Smani Hajami, Tarik; Rosado, Juan Antonio
Publisher: MDPI AC
Year: 2018
DOI: 10.3390/cancers10090331
Source: https://idus.us.es/bitstreams/685a6ce5-1743-4d15-8139-7d0e944af0ab/download
cance s
A icle
TRPC6 Channels A e Requi ed o P oli e a ion,
Mig a ion and In asion o B eas Cance Cell Lines
by Modula ion o O ai1 and O ai3 Su ace Exposu e
Isaac Ja din 1,†,* , Raquel Diez-Bello 1,†, Jose J. Lopez 1, Ped o C. Redondo 1,
Ginés M. Salido 1, Ta ik Smani 2and Juan A. Rosado 1,*
1Cellula Physiology Resea ch G oup, Depa men o Physiology, Ins i u e o Molecula Pa hology
Bioma ke s, Uni e si y o Ex emadu a, 10003 Cace es, Spain; [email p o ec ed] (R.D.-B.);
[email p o ec ed] (J.J.L.); [email p o ec ed] (P.C.R.); [email p o ec ed] (G.M.S.)
2Depa men o Medical Physiology and Biophysic, Ins i u e o Biomedicine o Se illa, 41013 Se illa, Spain;
[email p o ec ed]
*Co espondence: [email p o ec ed] (I.J.); [email p o ec ed] (J.A.R.);
Tel.: +34-927257100 (ex . 51376) (I.J. & J.A.R.);
Fax: +34-927257110 (I.J. & J.A.R.)
† These au ho s con ibu ed equally o his wo k.
Recei ed: 5 Augus 2018; Accep ed: 13 Sep embe 2018; Published: 14 Sep embe 2018


Abs ac :
T ansien ecep o po en ial channels con ey signaling in o ma ion om a numbe o
s imuli o a wide a ie y o cellula unc ions, mainly by inducing changes in cy osolic Ca
2+
concen a ion. Di e en membe s o he TRPC, TRPM and TRPV sub amilies ha e been epo ed o
play a ole in umo igenesis. He e we show ha he es ogen ecep o posi i e and iple nega i e
b eas cance cell lines, MCF7 and MDA-MB-231, espec i ely, exhibi enhanced exp ession o he
TRPC6 channel as compa ed o he non- umo al MCF10A cell line.
In i o
TRPC6 knockdown using
shRNA impai ed MCF7 and MDA-MB-231 cell p oli e a ion, mig a ion and in asion de ec ed by
B dU inco po a ion, wound healing and Boyden chambe assays, espec i ely. Using RNAi-media ed
TRPC6 silencing as well as o e exp ession o he po e-dead dominan -nega i e TRPC6 mu an we
ha e ound ha TRPC6 plays a ele an ole in he ac i a ion o s o e-ope a ed Ca
2+
en y in he b eas
cance cell lines bu no in non- umo al b eas cells. Finally, we ha e ound ha TRPC6 in e ac s
wi h O ai1 and O ai3 in MCF7 and MDA-MB-231 cells and is equi ed o he ansloca ion o O ai1
and O ai3 o he plasma memb ane in MDA-MB-231 and MCF7 cells, espec i ely, upon Ca
2+
s o e
deple ion. These indings in oduce a no el mechanism o he modula ion o Ca
2+
in lux and he
de elopmen o di e en cance hallma ks in b eas cance cells.
Keywo ds: TRPC6; O ai1; O ai3; s o e-ope a ed calcium en y; MCF7; MDA-MB-231
1. In oduc ion
B eas cance is among he leading causes o cance dea h in women wo ldwide, accoun ing
o abou 25% o all diagnosed emale cance s [
1
]. B eas cance cells a e cha ac e ized by a high
p oli e a ion a e, esis ance o p og ammed cell dea h, and inc eased capabili y o mig a e and in ade
su ounding issues [
2
]. These hallma ks can de elop h ough di e en mechanisms ha lead o he
onse and p og ession o b eas cance , among hem he al e a ion in he PI3K pa hway [
3
], abno mal
ac i a ion o he MAPK signaling [4] o anomalous in acellula Ca2+ signaling [5].
Cy osolic ee-Ca
2+
concen a ion is a c ucial ac o o a a ie y o cellula p ocesses [
6
] and a
numbe o genes encoding ion channels ha e been ound among hose al e ed in cance cells [
7
]. The e
is a g owing body o e idence suppo ing he ele an ole o ion channels, and pa icula ly Ca
2+
Cance s 2018,10, 331; doi:10.3390/cance s10090331 www.mdpi.com/jou nal/cance s
Cance s 2018,10, 331 2 o 18
channels, in he mechanisms unde lying cell g ow h and p oli e a ion, mig a ion, apop osis esis ance
and angiogenesis in cance cells. Among he Ca
2+
channels in cance cells, O ai1,
he po e- o ming
subuni o he Ca
2+
elease-ac i a ed Ca
2+
(CRAC) channel [
8
,
9
], which is he bes cha ac e ized
s o e-ope a ed Ca
2+
channel, has been ound o be o e exp essed in he human cance cells in es iga ed,
including b eas cance [
10
], melanoma [
11
], clea cell enal ca cinoma [
12
] and non-small cell lung
ca cinoma [
13
], excep in p os a e cance cells, whose exp ession has been epo ed o be educed as
compa ed o no mal issue [
14
]. The in o ma ion conce ning he O ai1 homologs O ai2 and O ai3 is
a he sca ce bu O ai2 has been ound o be o e exp essed in pa a hy oid adenoma [
15
] and acu e
myeloid leukemia cells [
16
], while O ai3 is o e exp essed in es ogen ecep o -exp essing (ER
+
) b eas
cance cell lines [
17
] and in p os a e cance issue specimens ob ained om esec ion su ge ies as
compa ed o noncance ous issue [18].
On he o he hand, ansien ecep o po en ial (TRP) channels, especially ce ain membe s
o he TRPC, TRPM and TRPV sub amilies, ha e also been epo ed o play a ele an ole in he
p og ession o di e en ypes o cance . Among hem, TRPV6 is o e exp essed in a numbe o
cance cell ypes and pa icipa es in he p og ession o p os a e cance [
19
], acqui ing i s oncogenic
po en ial ia O ai1/TRPC1-dependen ansloca ion o he plasma memb ane [
20
]. TRPM8 egula es
he mo ili y o a a ie y o cance cells including o al squamous ca cinoma, lung cance o p os a e
cance cells [
21
], whe e i s plasma memb ane localiza ion and umo igenic po en ial a e egula ed by
TRP channel-associa ed ac o s [
22
]. S udies conce ning TRPC sub amily membe s ha e mainly ocused
on TRPC1, whose in ol emen in umo igenesis a ies depending on he s age and ype o cance
conside ed [
21
,
23
]. TRPC6 has been epo ed o play a ele an ole in he p oli e a ion o gas ic [
24
],
p os a e [
25
], esophageal squamous cell ca cinoma [
26
] and hepa ome cells [
27
]. Fu he mo e, TRPC6
is equi ed o mig a ion and in asion o hepa ocellula ca cinoma cells [
28
]. TRPC6 channels ha e
been shown o be o e exp essed in human b eas duc al adenoca cinoma compa ed o non- umo al
issue [
29
,
30
] and bo h, TRPC3 and TRPC6, ha e been epo ed o be signi ican ly up- egula ed in
b eas cance biopsies compa ed o no mal issue [
31
]; howe e , he molecula basis o he unc ional
ole o TRPC6 in b eas cance cells and i s in ol emen in he cance hallma ks emains unclea .
He e we show ha TRPC6 is equi ed o p oli e a ion, mig a ion and in asion o he ER
+
cell
line MCF7 and he iple nega i e MDA-MB-231 cell line. Silencing TRPC6 p o ein exp ession, as well
as o e exp ession o a po e-dead dominan -nega i e TRPC6 mu an has e ealed ha TRPC6 plays an
impo an ole in he ac i a ion o s o e-ope a ed Ca
2+
en y (SOCE) in bo h MCF7 and MDA-MB-231
cell lines, which is likely media ed by he ole o TRPC6 in he ansloca ion o he plasma memb ane
o O ai3 o O ai1, espec i ely, in he cell lines in es iga ed.
2. Resul s
2.1. TRPC6 Is O e exp essed in MCF7 and MDA-MB-231 B eas Cance Cell Lines and is Requi ed o B eas
Cance Cell P oli e a ion, Mig a ion and In asion
Consis en wi h he p e ious s udy by Ayda and cowo ke s [
31
], Wes e n blo analysis o whole
cell lysa es om he non- umo al b eas MCF10A cell line, he ER
+
and iple nega i e b eas cance
cell lines MCF7 and MDA-MB-231, espec i ely, wi h a speci ic an i-human TRPC6 an ibody e ealed
ha he exp ession o his p o ein is ela i ely low in he non- umo al cell line (Figu e 1). Fu he mo e,
TRPC6 exp ession in he MCF7 and MDA-MB-231 cell lines is signi ican ly g ea e (app oxima ely
350 and 460%, espec i ely) han in non- umo al cells. TRPC6 exp ession in he di e en cell lines,
no malized o he
β
-ac in con en and exp essed as pe cen age o he exp ession le el in MCF10A,
is shown in Figu e 1(ba g aphs; n = 6).
We ha e u he explo ed he in ol emen o TRPC6 in he abili y o MCF10A, MCF7 and
MDA-MB-231 o p oli e a e. To add ess his issue, cells ans ec ed wi h shTRPC6 o shRNA con ol
ec o (shRNAc ), we e subjec ed o he B dU cell p oli e a ion assay.
Cance s 2018,10, 331 3 o 18
Cance s 2018, 10, 331 3 o 18
Figu e 1. Cellula exp ession o TRPC6 in non- umo al and b eas cance cell lines. MCF10A, MCF7
and MDA-MB-231 cells we e lysed and subjec ed o Wes e n blo ing wi h an i-TRPC6 an ibody,
ollowed by ep obing wi h an i-β-ac in an ibody o p o ein loading con ol. Ba g aphs ep esen
TRPC6 exp ession no malized o he β-ac in con en and exp essed as pe cen age o he TRPC6
exp ession in non- umo al MCF10A cells. Molecula masses indica ed on he igh we e de e mined
using molecula -mass ma ke s un in he same gel. * p < 0.05 compa ed o TRPC6 exp ession in
MCF10A cells.
As shown in Figu e 2a, cell ans ec ion wi h shTRPC6 signi ican ly a enua ed TRPC6
exp ession in MCF10A, MCF7 and MDA-MB-231 cells (p < 0.05; n = 6). Nex , we explo ed he e ec
o ans ec ion wi h shTRPC6 in cell p oli e a ion in he h ee cell lines. Fo y-eigh hou s a e
ans ec ion ( ime = 0h), as well as 24, 48 and 72h la e , cell p oli e a ion was assessed. As expec ed,
he shTRPC6 was wi hou e ec in MCF10A p oli e a ion, which is consis en wi h he low na i e
TRPC6 exp ession and indica es a lack o e ec o shTRPC6 in cell p oli e a ion in his cell line (Figu e
2b; n = 6). In e es ingly, silencing TRPC6 p o ein exp ession signi ican ly a enua ed MCF7 and MDA-
MB-231 cell p oli e a ion a all he imes in es iga ed as compa ed o cells ans ec ed wi h shRNAc
(Figu e 2b; p < 0.05; n = 4). The e o e, ou obse a ions e eal ha TRPC6 is essen ial o ER+ and
iple nega i e b eas cance cell p oli e a ion.
Nex , we assessed he ele ance o TRPC6 in he abili y o hese cell lines o mig a e. MCF10A,
MCF7 and MDA-MB-231 cells we e subjec ed o he well-es ablished wound healing assay. Cells
we e seeded, sc a ched, and cul u ed in medium supplemen ed wi h 1% se um o p e en u he
cell g ow h. Mig a ion o cells was quan i a ed as desc ibed in Ma e ials and Me hods. To explo e
he ole o TRPC6 in cell mig a ion MCF10A, MCF7 and MDA-MB-231 cells we e ans ec ed wi h
shTRPC6 o con ol plasmid and cell mig a ion was e alua ed. As shown in Figu e 3a, MCF10A,
MCF7 and MDA-MB-231 cells ans ec ed wi h shRNAc signi ican ly educed he wound size
du ing he i s 48 h (p < 0.05; n = 3). TRPC6 exp ession silencing did no a ec he abili y o MCF10A
o mig a e (Figu e 3a; n = 3), which is consis en wi h he low exp ession o TRPC6 in his cell line.
In e es ingly, silencing TRPC6 exp ession signi ican ly a enua ed MCF7 and MDA-MB-231
mig a ion as compa ed o cells ans ec ed wi h shRNAc (Figu e 3a; p < 0.05; n = 3), which indica es
ha TRPC6 plays an impo an ole in MCF7 and MDA-MB-231 cell mig a ion.
We ha e u he in es iga ed he ole o TRPC6 in in i o in asion analysed using he answell
mig a ion assay. A e ans ec ion wi h shRNAc , a signi ican amoun o MCF7 and MDA-MB-231
cells, especially he la e , passed ac oss he answell inse (Figu e 3b). We e en ound a la ge
numbe o MDA-MB-231 cells adhe ed o he su ace o he lowe chambe (Figu e 3b, bo om panel).
By con as , we we e unable o de ec MCF10A cells in he unde su ace o he answell inse [32].
In e es ingly, as depic ed in Figu e 3b, a lesse numbe o MCF7 and MDA-MB-231 cells we e able o
mig a e o he unde su ace o he answell inse upon TRPC6 exp ession silencing as compa ed o
cells ea ed wi h con ol shRNA (p < 0.05; n = 5). Consis en ly, he numbe o in asi e MDA-MB-231
cells a ached o he su ace o he lowe chambe was clea ly educed a e ans ec ion wi h
shTRPC6 (Figu e 3b, bo om panel).
Figu e 1.
Cellula exp ession o TRPC6 in non- umo al and b eas cance cell lines. MCF10A, MCF7
and MDA-MB-231 cells we e lysed and subjec ed o Wes e n blo ing wi h an i-TRPC6 an ibody,
ollowed by ep obing wi h an i-
β
-ac in an ibody o p o ein loading con ol. Ba g aphs ep esen
TRPC6 exp ession no malized o he
β
-ac in con en and exp essed as pe cen age o he TRPC6
exp ession in non- umo al MCF10A cells. Molecula masses indica ed on he igh we e de e mined
using molecula -mass ma ke s un in he same gel. * p< 0.05 compa ed o TRPC6 exp ession in
MCF10A cells.
As shown in Figu e 2a, cell ans ec ion wi h shTRPC6 signi ican ly a enua ed TRPC6 exp ession
in MCF10A, MCF7 and MDA-MB-231 cells (p< 0.05; n = 6). Nex , we explo ed he e ec o ans ec ion
wi h shTRPC6 in cell p oli e a ion in he h ee cell lines. Fo y-eigh hou s a e ans ec ion (
ime = 0 h
),
as well as 24, 48 and 72 h la e , cell p oli e a ion was assessed. As expec ed, he shTRPC6 was wi hou
e ec in MCF10A p oli e a ion, which is consis en wi h he low na i e TRPC6 exp ession and indica es
a lack o e ec o shTRPC6 in cell p oli e a ion in his cell line (Figu e 2b; n = 6). In e es ingly, silencing
TRPC6 p o ein exp ession signi ican ly a enua ed MCF7 and MDA-MB-231 cell p oli e a ion a all
he imes in es iga ed as compa ed o cells ans ec ed wi h shRNAc (Figu e 2b; p< 0.05; n = 4).
The e o e, ou obse a ions e eal ha TRPC6 is essen ial o ER
+
and iple nega i e b eas cance
cell p oli e a ion.
Nex , we assessed he ele ance o TRPC6 in he abili y o hese cell lines o mig a e. MCF10A,
MCF7 and MDA-MB-231 cells we e subjec ed o he well-es ablished wound healing assay. Cells
we e seeded, sc a ched, and cul u ed in medium supplemen ed wi h 1% se um o p e en u he cell
g ow h. Mig a ion o cells was quan i a ed as desc ibed in Ma e ials and Me hods. To explo e he ole
o TRPC6 in cell mig a ion MCF10A, MCF7 and MDA-MB-231 cells we e ans ec ed wi h shTRPC6
o con ol plasmid and cell mig a ion was e alua ed. As shown in Figu e 3a, MCF10A, MCF7 and
MDA-MB-231 cells ans ec ed wi h shRNAc signi ican ly educed he wound size du ing he i s
48 h (p< 0.05; n = 3). TRPC6 exp ession silencing did no a ec he abili y o MCF10A o mig a e
(Figu e 3a; n = 3), which is consis en wi h he low exp ession o TRPC6 in his cell line. In e es ingly,
silencing TRPC6 exp ession signi ican ly a enua ed MCF7 and MDA-MB-231 mig a ion as compa ed
o cells ans ec ed wi h shRNAc (Figu e 3a; p< 0.05; n = 3), which indica es ha TRPC6 plays an
impo an ole in MCF7 and MDA-MB-231 cell mig a ion.
We ha e u he in es iga ed he ole o TRPC6 in
in i o
in asion analysed using he answell
mig a ion assay. A e ans ec ion wi h shRNAc , a signi ican amoun o MCF7 and MDA-MB-231
cells, especially he la e , passed ac oss he answell inse (Figu e 3b). We e en ound a la ge
numbe o MDA-MB-231 cells adhe ed o he su ace o he lowe chambe (Figu e 3b, bo om panel).
By con as
, we we e unable o de ec MCF10A cells in he unde su ace o he answell inse [
32
].
In e es ingly, as depic ed in Figu e 3b, a lesse numbe o MCF7 and MDA-MB-231 cells we e able o
mig a e o he unde su ace o he answell inse upon TRPC6 exp ession silencing as compa ed o
cells ea ed wi h con ol shRNA (p< 0.05; n = 5). Consis en ly, he numbe o in asi e MDA-MB-231
cells a ached o he su ace o he lowe chambe was clea ly educed a e ans ec ion wi h shTRPC6
(Figu e 3b, bo om panel).
Cance s 2018,10, 331 4 o 18
Cance s 2018, 10, 331 4 o 18
Figu e 2. TRPC6 exp ession is equi ed o MCF7 and MDA-MB-231 cell p oli e a ion. (a) MCF10A,
MCF7 and MDA-MB-231 cells we e ans ec ed wi h shTRPC6 o shRNA con ol ec o (shRNAc ),
as indica ed. A e 48h cells we e lysed and subjec ed o Wes e n blo ing wi h an i-TRPC6 an ibody,
ollowed by ep obing wi h an i-β-ac in an ibody o p o ein loading con ol. Molecula masses
indica ed on he igh we e de e mined using molecula -mass ma ke s un in he same gel. (b)
MCF10A, MCF7 and MDA-MB-231 cells we e ans ec ed wi h shTRPC6 o sc amble plasmid and 48
h la e cell p oli e a ion was assessed o a u he 24, 48 and 72 h using he B dU cell p oli e a ion
assay ki , as desc ibed in he Ma e ial and Me hods. Ba g aphs ep esen cell p oli e a ion 0, 24, 48
and 72 h a e cell ans ec ion, p esen ed as B dU up ake a e. * p < 0.05 compa ed o he
co esponding con ol (cells ans ec ed wi h shRNAc ).
Figu e 3. Con .
Figu e 2.
TRPC6 exp ession is equi ed o MCF7 and MDA-MB-231 cell p oli e a ion. (
a
) MCF10A,
MCF7 and MDA-MB-231 cells we e ans ec ed wi h shTRPC6 o shRNA con ol ec o (shRNAc ),
as indica ed. A e 48h cells we e lysed and subjec ed o Wes e n blo ing wi h an i-TRPC6 an ibody,
ollowed by ep obing wi h an i-
β
-ac in an ibody o p o ein loading con ol. Molecula masses
indica ed on he igh we e de e mined using molecula -mass ma ke s un in he same gel.
(b) MCF10A
,
MCF7 and MDA-MB-231 cells we e ans ec ed wi h shTRPC6 o sc amble plasmid and 48 h la e
cell p oli e a ion was assessed o a u he 24, 48 and 72 h using he B dU cell p oli e a ion assay ki ,
as desc ibed
in he Ma e ial and Me hods. Ba g aphs ep esen cell p oli e a ion 0, 24, 48 and 72 h
a e cell ans ec ion, p esen ed as B dU up ake a e. * p< 0.05 compa ed o he co esponding con ol
(cells ans ec ed wi h shRNAc ).
Cance s 2018, 10, 331 4 o 18
Figu e 2. TRPC6 exp ession is equi ed o MCF7 and MDA-MB-231 cell p oli e a ion. (a) MCF10A,
MCF7 and MDA-MB-231 cells we e ans ec ed wi h shTRPC6 o shRNA con ol ec o (shRNAc ),
as indica ed. A e 48h cells we e lysed and subjec ed o Wes e n blo ing wi h an i-TRPC6 an ibody,
ollowed by ep obing wi h an i-β-ac in an ibody o p o ein loading con ol. Molecula masses
indica ed on he igh we e de e mined using molecula -mass ma ke s un in he same gel. (b)
MCF10A, MCF7 and MDA-MB-231 cells we e ans ec ed wi h shTRPC6 o sc amble plasmid and 48
h la e cell p oli e a ion was assessed o a u he 24, 48 and 72 h using he B dU cell p oli e a ion
assay ki , as desc ibed in he Ma e ial and Me hods. Ba g aphs ep esen cell p oli e a ion 0, 24, 48
and 72 h a e cell ans ec ion, p esen ed as B dU up ake a e. * p < 0.05 compa ed o he
co esponding con ol (cells ans ec ed wi h shRNAc ).
Figu e 3. Con .
Figu e 3. Con .
Cance s 2018,10, 331 5 o 18
Cance s 2018, 10, 331 5 o 18
Figu e 3. Role o TRPC6 in b eas cance cell mig a ion and in asion. MCF10A, MCF7 and MDA-MB-
231 cells we e ans ec ed wi h shTRPC6 o con ol shRNAc . Fo y-eigh hou s a e ans ec ion
cells we e subjec ed o wound healing assay (a) o answell mig a ion assay (b) as desc ibed in
Me hods. (a) Images we e acqui ed a 0 and 48 h om he beginning o he assay. The do ed lines
de ine he a eas lacking cells. The ba g aphs ep esen he wound size, in mic ome e s, a he
di e en condi ions, exp essed as he mean ± SEM o h ee independen expe imen s. * p < 0.05
compa ed o he ime = 0 h. § p < 0.05 compa ed o he co esponding ime in shRNAc ans ec ed
cells. (b) Images show he s ained cells as ob ained om he answell mig a ion assay subjec ed o
he di e en expe imen al condi ions. The ba g aphs ep esen he pe cen age o cell in asion as
compa ed o MDA-MB-231 cells ans ec ed wi h shRNAc , exp essed as he mean ± SEM o i e
independen expe imen s. * p < 0.05 compa ed o he co esponding shRNAc ans ec ed cells.
Bo om panels show ep esen a i e pic u es o he in asi e cells adhe ed o he bo om o he lowe
chambe .
Figu e 3.
Role o TRPC6 in b eas cance cell mig a ion and in asion. MCF10A, MCF7 and
MDA-MB-231 cells we e ans ec ed wi h shTRPC6 o con ol shRNAc . Fo y-eigh hou s a e
ans ec ion cells we e subjec ed o wound healing assay (
a
) o answell mig a ion assay (
b
) as
desc ibed in Me hods. (
a
) Images we e acqui ed a 0 and 48 h om he beginning o he assay.
The do ed
lines de ine he a eas lacking cells. The ba g aphs ep esen he wound size, in mic ome e s,
a he di e en condi ions, exp essed as he mean
±
SEM o h ee independen expe imen s. * p< 0.05
compa ed o he ime = 0 h. § p< 0.05 compa ed o he co esponding ime in shRNAc ans ec ed
cells. (
b
) Images show he s ained cells as ob ained om he answell mig a ion assay subjec ed o
he di e en expe imen al condi ions. The ba g aphs ep esen he pe cen age o cell in asion as
compa ed o MDA-MB-231 cells ans ec ed wi h shRNAc , exp essed as he mean
±
SEM o i e
independen expe imen s. * p< 0.05 compa ed o he co esponding shRNAc ans ec ed cells. Bo om
panels show ep esen a i e pic u es o he in asi e cells adhe ed o he bo om o he lowe chambe .

Cance s 2018,10, 331 6 o 18
We con i med he ole o TRPC6 in b eas cance cell mig a ion and p oli e a ion by exp essing
a po e-dead dominan -nega i e TRPC6 (TRPC6dn) mu an . As shown in Figu e 4a, exp ession o
he TRPC6dn mu an signi ican ly educed MCF7 and MDA-MB-231 mig a ion as compa ed o cells
ans ec ed wi h emp y ec o (p< 0.05; n = 3).
Cance s 2018, 10, 331 6 o 18
We con i med he ole o TRPC6 in b eas cance cell mig a ion and p oli e a ion by exp essing
a po e-dead dominan -nega i e TRPC6 (TRPC6dn) mu an . As shown in Figu e 4a, exp ession o he
TRPC6dn mu an signi ican ly educed MCF7 and MDA-MB-231 mig a ion as compa ed o cells
ans ec ed wi h emp y ec o (p < 0.05; n = 3).
Figu e 4. Exp ession o TRPC6dn mu an a enua es cell mig a ion and p oli e a ion in b eas cance
cells. (a) MCF7 and MDA-MB-231 cells we e ans ec ed wi h TRPC6dn exp ession plasmid o emp y
ec o (mock), as indica ed. Fo y-eigh hou s a e ans ec ion cells we e subjec ed o wound healing
assay as desc ibed in Me hods. Images we e acqui ed a 0 and 48 h om he beginning o he assay.
The do ed lines de ine he a eas lacking cells. The ba g aphs ep esen he wound size, in
mic ome e s, a he di e en condi ions, exp essed as he mean ± SEM o h ee independen
expe imen s. * p < 0.05 compa ed o he ime = 0h. § p < 0.05 compa ed o he co esponding ime in
mock- ea ed cells. (b) MCF7 and MDA-MB-231 cells we e ans ec ed wi h TRPC6dn exp ession
plasmid o emp y ec o (mock), as indica ed, and 48 h la e cell p oli e a ion was assessed o a
u he 24, 48 and 72 h using he B dU cell p oli e a ion assay ki , as desc ibed in he Ma e ial and
Me hods. Ba g aphs ep esen cell p oli e a ion 0, 24, 48 and 72 h a e cell ans ec ion, p esen ed as
B dU up ake a e. * p < 0.05 compa ed o he co esponding con ol (mock- ans ec ed cells).
Figu e 4.
Exp ession o TRPC6dn mu an a enua es cell mig a ion and p oli e a ion in b eas cance
cells. (
a
) MCF7 and MDA-MB-231 cells we e ans ec ed wi h TRPC6dn exp ession plasmid o emp y
ec o (mock), as indica ed. Fo y-eigh hou s a e ans ec ion cells we e subjec ed o wound healing
assay as desc ibed in Me hods. Images we e acqui ed a 0 and 48 h om he beginning o he assay.
The do ed
lines de ine he a eas lacking cells. The ba g aphs ep esen he wound size, in mic ome e s,
a he di e en condi ions, exp essed as he mean
±
SEM o h ee independen expe imen s.
*p< 0.05
compa ed o he ime = 0 h. § p< 0.05 compa ed o he co esponding ime in mock- ea ed cells.
(b) MCF7
and MDA-MB-231 cells we e ans ec ed wi h TRPC6dn exp ession plasmid o emp y ec o
(mock), as indica ed, and 48 h la e cell p oli e a ion was assessed o a u he 24, 48 and 72 h using
he B dU cell p oli e a ion assay ki , as desc ibed in he Ma e ial and Me hods. Ba g aphs ep esen
cell p oli e a ion 0, 24, 48 and 72 h a e cell ans ec ion, p esen ed as B dU up ake a e. * p< 0.05
compa ed o he co esponding con ol (mock- ans ec ed cells).
Cance s 2018,10, 331 7 o 18
Fu he mo e, exp ession o he TRPC6dn mu an signi ican ly a enua ed MCF7 and MDA-MB-231
cell p oli e a ion a all he imes in es iga ed as compa ed o cells ans ec ed wi h emp y ec o
(Figu e 4b; p< 0.05; n = 3). These indings con i m ha TRPC6 is equi ed o MCF7 and MDA-MB-231
b eas cance cells mig a ion and p oli e a ion.
2.2. Func ional Role o TRPC6 in SOCE in B eas Cance Cell Lines
As ou esul s indica e ha TRPC6 knockdown signi ican ly a enua es ele an ea u es o cance
cells, such as p oli e a ion, mig a ion and
in i o
in asion, we ha e explo ed he possible mechanism
unde lying he unc ional ole o TRPC6 in hese cells. SOCE has been epo ed o play an impo an
ole suppo ing se e al cance hallma ks [
16
,
33
,
34
]. Hence, we ha e e alua ed whe he TRPC6
plays a ole in he ac i a ion o SOCE in b eas cance cells by ans ec ing non- umo al MCF10A
and cance MCF7 and MDA-MB-231 cells wi h shTRPC6 o shRNAc , as con ol. As depic ed in
Figu e 5a–c,
in cells ans ec ed
wi h shRNAc suspended in a Ca
2+
- ee medium, ea men wi h
he SERCA inhibi o TG (1
µ
M) esul ed in a ansien inc ease in cy osolic ee-Ca
2+
concen a ion
due o Ca
2+
elease om he in acellula Ca
2+
s o es. Subsequen addi ion o CaCl
2
(1 mM) o he
ex acellula medium esul ed in a u he inc ease in cy osolic ee-Ca
2+
concen a ion indica i e
o SOCE. TG-induced Ca
2+
elease was simila in all he cell lines in es iga ed while Ca
2+
in lux
was signi ican ly g ea e in MDA-MB-231 cells (Figu e 5g,h; p< 0.05; n = 40 cells/day/3–5 days).
A enua ion o TRPC6 exp ession by cell ans ec ion wi h shTRPC6 signi ican ly inhibi ed SOCE in
MCF7 and MDA-MB-231 cells by 70%, wi hou ha ing any e ec on Ca
2+
elease om he in acellula
s o es (Figu e 5a–c,g–h; p< 0.05). T ans ec ion o MCF10A cells wi h shTRPC6 did no signi ican ly
al e TG-induced Ca
2+
elease o en y, which is consis en wi h he low TRPC6 exp ession a he
p o ein le el in hese cells. Al oge he hese indings indica e ha TRPC6 plays a ele an ole in
he ac i a ion o SOCE in MCF7 and MDA-MB-231 b eas cance cells while his p o ein has no a
de ec able ole in non- umo al MCF10A cells.
Cance s 2018, 10, 331 7 o 18
Fu he mo e, exp ession o he TRPC6dn mu an signi ican ly a enua ed MCF7 and MDA-MB-
231 cell p oli e a ion a all he imes in es iga ed as compa ed o cells ans ec ed wi h emp y ec o
(Figu e 4b; p < 0.05; n = 3). These indings con i m ha TRPC6 is equi ed o MCF7 and MDA-MB-
231 b eas cance cells mig a ion and p oli e a ion.
2.2. Func ional Role o TRPC6 in SOCE in B eas Cance Cell Lines
As ou esul s indica e ha TRPC6 knockdown signi ican ly a enua es ele an ea u es o
cance cells, such as p oli e a ion, mig a ion and in i o in asion, we ha e explo ed he possible
mechanism unde lying he unc ional ole o TRPC6 in hese cells. SOCE has been epo ed o play
an impo an ole suppo ing se e al cance hallma ks [16,33,34]. Hence, we ha e e alua ed whe he
TRPC6 plays a ole in he ac i a ion o SOCE in b eas cance cells by ans ec ing non- umo al
MCF10A and cance MCF7 and MDA-MB-231 cells wi h shTRPC6 o shRNAc , as con ol. As
depic ed in Figu e 5a–c, in cells ans ec ed wi h shRNAc suspended in a Ca2+- ee medium,
ea men wi h he SERCA inhibi o TG (1 µM) esul ed in a ansien inc ease in cy osolic ee-Ca2+
concen a ion due o Ca2+ elease om he in acellula Ca2+ s o es. Subsequen addi ion o CaCl2 (1
mM) o he ex acellula medium esul ed in a u he inc ease in cy osolic ee-Ca2+ concen a ion
indica i e o SOCE. TG-induced Ca2+ elease was simila in all he cell lines in es iga ed while Ca2+
in lux was signi ican ly g ea e in MDA-MB-231 cells (Figu e 5g,h; p < 0.05; n = 40 cells/day/3-5 days).
A enua ion o TRPC6 exp ession by cell ans ec ion wi h shTRPC6 signi ican ly inhibi ed SOCE in
MCF7 and MDA-MB-231 cells by 70%, wi hou ha ing any e ec on Ca2+ elease om he in acellula
s o es (Figu es 5a–c and 4g–h; p < 0.05). T ans ec ion o MCF10A cells wi h shTRPC6 did no
signi ican ly al e TG-induced Ca2+ elease o en y, which is consis en wi h he low TRPC6
exp ession a he p o ein le el in hese cells. Al oge he hese indings indica e ha TRPC6 plays a
ele an ole in he ac i a ion o SOCE in MCF7 and MDA-MB-231 b eas cance cells while his
p o ein has no a de ec able ole in non- umo al MCF10A cells.
Figu e 5. Con .
Figu e 5. Con .
Cance s 2018,10, 331 8 o 18
Cance s 2018, 10, 331 8 o 18
Figu e 5. TRPC6 is equi ed o s o e-ope a ed Ca2+ en y in b eas cance cell lines. (a–c) MCF10A,
MCF7 and MDA-MB-231 cells we e ans ec ed wi h shTRPC6 o sc amble plasmid (shRNAc ), as
indica ed. Fo y-eigh hou s a e ans ec ion, u a-2-loaded cells we e pe used wi h a Ca2+- ee
medium (100 µM EGTA added) and hen s imula ed wi h TG (1 µM) ollowed by ein oduc ion o
ex e nal Ca2+ ( inal concen a ion 1 mM) o ini ia e Ca2+ en y. Da a a e mean ± SEM o 40 cells/day/3-
5 days. (d– ) MCF7 and MDA-MB-231 cells we e ans ec ed wi h TRPC6dn mu an exp ession
plasmid o emp y ec o (mock), as indica ed. A e 48 h cells we e lysed and subjec ed o wes e n
blo ing wi h an i-TRPPC6 an ibody, ollowed by ep obing wi h an i-β-ac in an ibody o p o ein
loading con ol (d). Molecula masses indica ed on he igh we e de e mined using molecula -mass
ma ke s un in he same gel. (e and ) Fo y-eigh hou s a e ans ec ion, u a-2-loaded cells we e
pe used wi h a Ca2+- ee medium (100 µM EGTA added) and hen s imula ed wi h TG (1 µM)
ollowed by ein oduc ion o ex e nal Ca2+ ( inal concen a ion 1 mM) o ini ia e Ca2+ en y. Da a a e
mean ± SEM o 40 cells/day/3-5 days. Ba g aphs ep esen TG-induced Ca2+ elease (g) and en y (h)
in MCF10A, MCF7 and MDA-MB-231 cells un ea ed o ans ec ed wi h he indica ed plasmids. Da a
a e exp essed as mean ± SEM and p esen ed as pe cen age o con ol (MCF10A cells ea ed wi h
sc amble plasmid). * ep esen s p < 0.05 as compa ed o sc amble- ea ed MCF10A cells. § ep esen s
p < 0.05 as compa ed o he same cell line ans ec ed wi h shRNAc .
In o de o u he explo e whe he he obse ed e ec depends on ca ion en y h ough he
channel o i is a he associa ed o a mechanism in ol ing he exp ession o he p o ein i sel , we
o e exp essed he TRPC6dn mu an in MCF7 and MDA-MB-231 cells and looked o i s e ec on TG-
induced Ca2+ elease and en y. As shown in Figu e 5d, TRPC6dn was e icien ly exp essed in bo h
cell ypes. As depic ed in Figu es 5e–h, o e exp ession o TRPC6dn in MCF7 and MDA-MB-231 cells
signi ican ly educed TG-e oked Ca2+ en y o a simila ex en o ans ec ion o shTRPC6 (p < 0.05 as
compa ed o con ol; n = 40 cells/day/3–5 days), which indica es ha ca ion in lux h ough TRPC6
plays an impo an ole in SOCE in hese cells. O e exp ession o TRPC6dn also esul ed in a
signi ican dec ease in he abili y o MCF7 cells o accumula e Ca2+ in o TG-sensi i e s o es (Figu e
5e,g; p < 0.05; n = 40 cells/day/3–5 days), an e ec ha migh be a ibu ed o he inhibi ion o SOCE.
Figu e 5.
TRPC6 is equi ed o s o e-ope a ed Ca
2+
en y in b eas cance cell lines. (
a
–
c
) MCF10A,
MCF7 and MDA-MB-231 cells we e ans ec ed wi h shTRPC6 o sc amble plasmid (shRNAc ),
as indica ed
. Fo y-eigh hou s a e ans ec ion, u a-2-loaded cells we e pe used wi h a Ca
2+
- ee
medium (100
µ
M EGTA added) and hen s imula ed wi h TG (1
µ
M) ollowed by ein oduc ion
o ex e nal Ca
2+
( inal concen a ion 1 mM) o ini ia e Ca
2+
en y. Da a a e mean
±
SEM o
40 cells/day/3–5 days
. (
d
–
) MCF7 and MDA-MB-231 cells we e ans ec ed wi h TRPC6dn mu an
exp ession plasmid o emp y ec o (mock), as indica ed. A e 48 h cells we e lysed and subjec ed
o wes e n blo ing wi h an i-TRPPC6 an ibody, ollowed by ep obing wi h an i-
β
-ac in an ibody
o p o ein loading con ol (
d
). Molecula masses indica ed on he igh we e de e mined using
molecula -mass ma ke s un in he same gel. (
e
and
) Fo y-eigh hou s a e ans ec ion, u a-2-loaded
cells we e pe used wi h a Ca
2+
- ee medium (100
µ
M EGTA added) and hen s imula ed wi h TG
(1
µ
M) ollowed by ein oduc ion o ex e nal Ca
2+
( inal concen a ion 1 mM) o ini ia e Ca
2+
en y.
Da a a e mean
±
SEM o 40 cells/day/3–5 days. Ba g aphs ep esen TG-induced Ca
2+
elease (
g
)
and en y (
h
) in MCF10A, MCF7 and MDA-MB-231 cells un ea ed o ans ec ed wi h he indica ed
plasmids. Da a a e exp essed as mean
±
SEM and p esen ed as pe cen age o con ol (MCF10A cells
ea ed wi h sc amble plasmid). * ep esen s p< 0.05 as compa ed o sc amble- ea ed MCF10A cells.
§ ep esen s p< 0.05 as compa ed o he same cell line ans ec ed wi h shRNAc .
In o de o u he explo e whe he he obse ed e ec depends on ca ion en y h ough he
channel o i is a he associa ed o a mechanism in ol ing he exp ession o he p o ein i sel , we
o e exp essed he TRPC6dn mu an in MCF7 and MDA-MB-231 cells and looked o i s e ec on
TG-induced Ca
2+
elease and en y. As shown in Figu e 5d, TRPC6dn was e icien ly exp essed in bo h
cell ypes. As depic ed in Figu e 5e–h, o e exp ession o TRPC6dn in MCF7 and MDA-MB-231 cells
signi ican ly educed TG-e oked Ca
2+
en y o a simila ex en o ans ec ion o shTRPC6 (
p< 0.05
as
compa ed o con ol; n = 40 cells/day/3–5 days), which indica es ha ca ion in lux h ough TRPC6
plays an impo an ole in SOCE in hese cells. O e exp ession o TRPC6dn also esul ed in a signi ican
dec ease in he abili y o MCF7 cells o accumula e Ca
2+
in o TG-sensi i e s o es (Figu e 5e,g; p< 0.05;
n = 40 cells/day/3–5 days), an e ec ha migh be a ibu ed o he inhibi ion o SOCE.
Cance s 2018,10, 331 9 o 18
2.3. TRPC6 Exp ession Is Requi ed o Plasma Memb ane Localiza ion o O ai1 and O ai3 in B eas
Cance Cells
B eas cance MCF7 and MDA-MB-231 cells ha e been epo ed o exp ess bo h O ai1 and O ai3
channels. Howe e , he ela i e exp ession le el and unc ion di e s om ER
+
MCF7 cells o iple
nega i e MDA-MB-231 cells [
35
]. While SOCE in MDA-MB-231 cells en i ely depends on O ai1, MCF7
SOCE is mainly media ed by O ai3, whose exp ession, egula ed by ER
α
[
17
], is p edominan o e
ha o O ai1 [
35
]. Ou esul s con i m ha O ai1 is o e exp essed in he b eas cance cell lines and
ha O ai3 exp ession is signi ican ly enhanced in MCF7 (Figu e 6a; p< 0.05; n = 6), as p e iously
epo ed [
35
]. In o de o explo e he mechanism unde lying he sensi i i y o SOCE o TRPC6
exp ession and unc ion we ha e i s in es iga ed he in e ac ion o TRPC6 wi h O ai1 and O ai3 by
co-immunop ecipi a ion om MCF7 and MDA-MB-231 cell lysa es. Res ing and TG- ea ed cells we e
used o his s udy o de e mine whe he Ca
2+
s o e deple ion plays any ole in he possible in e ac ion
be ween TRPC6 and he O ai p o eins in es iga ed. As shown in Figu e 6b,c, immunop ecipi a ion
o cell lysa es wi h an i-TRPC6 an ibody ollowed by Wes e n blo ing wi h an i-O ai1 o an i-O ai3
an ibody e eals ha TRPC6 in e ac s wi h bo h p o eins in es ing cells. In e es ingly, ou esul s
sugges ha in MCF7 cells he in e ac ion o TRPC6 wi h O ai3 is appa en ly g ea e han wi h O ai1,
and, con e sely, in MDA-MB-231 cells, TRPC6 seems o in e ac p edominan ly wi h O ai1 o e O ai3
(Figu e 6b,c; n = 6). Al hough hese appa en di e ences migh be a ibu ed o he use o wo di e en
an ibodies, i we look a he associa ion o TRPC6 wi h O ai1, whose exp ession we and o he s ha e
ound o be simila in MCF7 and MDA-MB-231 cells [
35
] (Figu e 6a), and we no malize he da a
wi h he amoun o TRPC6 pulled down, ou esul s indica e ha mo e O ai1 is bound o TRPC6 in
MDA-MB-231 cells (p< 0.05; n = 6). In addi ion, we ha e ound ha he in e ac ion o TRPC6 wi h
O ai1 and O ai3 is no al e ed by ea men wi h 1
µ
M TG o 3 min (Figu e 6b,c), which, as depic ed
in Figu e 5, is able o induce signi ican s o e deple ion.
Cance s 2018, 10, 331 9 o 18
2.3. TRPC6 Exp ession Is Requi ed o Plasma Memb ane Localiza ion o O ai1 and O ai3 in B eas Cance
Cells
B eas cance MCF7 and MDA-MB-231 cells ha e been epo ed o exp ess bo h O ai1 and O ai3
channels. Howe e , he ela i e exp ession le el and unc ion di e s om ER+ MCF7 cells o iple
nega i e MDA-MB-231 cells [35]. While SOCE in MDA-MB-231 cells en i ely depends on O ai1,
MCF7 SOCE is mainly media ed by O ai3, whose exp ession, egula ed by ER [17], is p edominan
o e ha o O ai1 [35]. Ou esul s con i m ha O ai1 is o e exp essed in he b eas cance cell lines
and ha O ai3 exp ession is signi ican ly enhanced in MCF7 (Figu e 6a; p < 0.05; n = 6), as p e iously
epo ed [35]. In o de o explo e he mechanism unde lying he sensi i i y o SOCE o TRPC6
exp ession and unc ion we ha e i s in es iga ed he in e ac ion o TRPC6 wi h O ai1 and O ai3 by
co-immunop ecipi a ion om MCF7 and MDA-MB-231 cell lysa es. Res ing and TG- ea ed cells
we e used o his s udy o de e mine whe he Ca2+ s o e deple ion plays any ole in he possible
in e ac ion be ween TRPC6 and he O ai p o eins in es iga ed. As shown in Figu e 6b,c,
immunop ecipi a ion o cell lysa es wi h an i-TRPC6 an ibody ollowed by Wes e n blo ing wi h
an i-O ai1 o an i-O ai3 an ibody e eals ha TRPC6 in e ac s wi h bo h p o eins in es ing cells.
In e es ingly, ou esul s sugges ha in MCF7 cells he in e ac ion o TRPC6 wi h O ai3 is appa en ly
g ea e han wi h O ai1, and, con e sely, in MDA-MB-231 cells, TRPC6 seems o in e ac
p edominan ly wi h O ai1 o e O ai3 (Figu e 6b,c; n = 6). Al hough hese appa en di e ences migh
be a ibu ed o he use o wo di e en an ibodies, i we look a he associa ion o TRPC6 wi h O ai1,
whose exp ession we and o he s ha e ound o be simila in MCF7 and MDA-MB-231 cells [35]
(Figu e 6a), and we no malize he da a wi h he amoun o TRPC6 pulled down, ou esul s indica e
ha mo e O ai1 is bound o TRPC6 in MDA-MB-231 cells (p < 0.05; n = 6). In addi ion, we ha e ound
ha he in e ac ion o TRPC6 wi h O ai1 and O ai3 is no al e ed by ea men wi h 1 µM TG o 3
min (Figu e 6b,c), which, as depic ed in Figu e 5, is able o induce signi ican s o e deple ion.
Figu e 6. Con .
Figu e 6. Con .
Cance s 2018,10, 331 16 o 18
6. Clapham, D.E. Calcium signaling. Cell 2007,131, 1047–1058. [C ossRe ] [PubMed]
7.
P e a skaya, N.; Sk yma, R.; Shuba, Y. Ion Channels in Cance : A e Cance Hallma ks Oncochannelopa hies?
Physiol. Re . 2018,98, 559–621. [C ossRe ] [PubMed]
8.
Feske, S.; Gwack, Y.; P ak iya, M.; S ikan h, S.; Puppel, S.H.; Tanasa, B.; Hogan, P.G.; Lewis, R.S.; Daly, M.;
e al. A mu a ion in O ai1 causes immune de iciency by ab oga ing CRAC channel unc ion. Na u e
2006
,
441, 179–185. [C ossRe ] [PubMed]
9.
Peinel , C.; Vig, M.; Koomoa, D.L.; Beck, A.; Nadle , M.J.; Koblan-Hube son, M.; Lis, A.; Fleig, A.; Penne , R.;
Kine , J.P. Ampli ica ion o CRAC cu en by STIM1 and CRACM1 (O ai1). Na . Cell Biol.
2006
,8, 771–773.
[C ossRe ] [PubMed]
10.
Chang, W.C.; Fang, Y.Y.; Chang, H.W.; Chuang, L.Y.; Lin, Y.D.; Hou, M.F.; Yang, C.H. Iden i ying associa ion
model o single-nucleo ide polymo phisms o ORAI1 gene o b eas cance . Cance Cell In .
2014
,14, 29.
[C ossRe ] [PubMed]
11.
S anisz, H.; Saul, S.; Mulle , C.S.; Kappl, R.; Niemeye , B.A.; Vog , T.; Ho h, M.; Roesch, A.; Bogeski, I. In e se
egula ion o melanoma g ow h and mig a ion by O ai1/STIM2-dependen calcium en y. Pigmen Cell
Melanoma Res. 2014,27, 442–453. [C ossRe ] [PubMed]
12.
Kim, J.H.; Lkhag ado j, S.; Lee, M.R.; Hwang, K.H.; Chung, H.C.; Jung, J.H.; Cha, S.K.; Eom, M. O ai1 and
STIM1 a e c i ical o cell mig a ion and p oli e a ion o clea cell enal cell ca cinoma. Biochem. Biophys.
Res. Commun. 2014,448, 76–82. [C ossRe ] [PubMed]
13.
Zhan, Z.Y.; Zhong, L.X.; Feng, M.; Wang, J.F.; Liu, D.B.; Xiong, J.P. O e -exp ession o O ai1 media es cell
p oli e a ion and associa es wi h poo p ognosis in human non-small cell lung ca cinoma. In . J. Clin.
Exp. Pa hol. 2015,8, 5080–5088. [PubMed]
14.
Flou akis, M.; Lehen’kyi, V.; Beck, B.; Raphael, M.; Vandenbe ghe, M.; Abeele, F.V.; Roudba aki, M.;
Lepage, G.; Mau oy, B.; Romanin, C.; e al. O ai1 con ibu es o he es ablishmen o an apop osis- esis an
pheno ype in p os a e cance cells. Cell Dea h Dis. 2010,1, e75. [C ossRe ] [PubMed]
15.
Haglund, F.; Ma, R.; Huss, M.; Sulaiman, L.; Lu, M.; Nilsson, I.L.; Hoog, A.; Juhlin, C.C.; Ha man, J.;
La sson, C. E idence o a unc ional es ogen ecep o in pa a hy oid adenomas. J. Clin. Endoc inol. Me ab.
2012,97, 4631–4639. [C ossRe ] [PubMed]
16.
Diez-Bello, R.; Ja din, I.; Salido, G.M.; Rosado, J.A. O ai1 and O ai2 media e s o e-ope a ed calcium en y
ha egula es HL60 cell mig a ion and FAK phospho yla ion. Biochim. Biophys. Ac a
2017
,1864, 1064–1070.
[C ossRe ] [PubMed]
17.
Mo iani, R.K.; Zhang, X.; Ha mon, K.E.; Kelle , R.S.; Ma ougui, K.; Benne , J.A.; T ebak, M. O ai3 is an
es ogen ecep o alpha- egula ed Ca(2)(+) channel ha p omo es umo igenesis. FASEB J.
2013
,27, 63–75.
[C ossRe ] [PubMed]
18.
Dubois, C.; Vanden Abeele, F.; Lehen’kyi, V.; Gkika, D.; Gua mi , B.; Lepage, G.; Slomianny, C.; Bo owiec, A.S.;
Bidaux, G.; Benahmed, M.; e al. Remodeling o channel- o ming ORAI p o eins de e mines an oncogenic
swi ch in p os a e cance . Cance Cell 2014,26, 19–32. [C ossRe ] [PubMed]
19.
Fixeme , T.; Wissenbach, U.; Flocke zi, V.; Bonkho , H. Exp ession o he Ca
2+
-selec i e ca ion channel
TRPV6 in human p os a e cance : A no el p ognos ic ma ke o umo p og ession. Oncogene
2003
,22,
7858–7861. [C ossRe ] [PubMed]
20.
Raphael, M.; Lehen’kyi, V.; Vandenbe ghe, M.; Beck, B.; Khalimonchyk, S.; Vanden Abeele, F.; Fa se i, L.;
Ge main, E.; Bokhobza, A.; Mihalache, A.; e al. TRPV6 calcium channel ansloca es o he plasma memb ane
ia O ai1-media ed mechanism and con ols cance cell su i al. P oc. Na l. Acad. Sci. USA
2014
,111,
E3870–E3879. [C ossRe ] [PubMed]
21.
Smani, T.; Shapo alo , G.; Sk yma, R.; P e a skaya, N.; Rosado, J.A. Func ional and physiopa hological
implica ions o TRP channels. Biochim. Biophys. Ac a 2015,1853, 1772–1782. [C ossRe ] [PubMed]
22.
Gkika, D.; Lemonnie , L.; Shapo alo , G.; Go dienko, D.; Poux, C.; Be na dini, M.; Bokhobza, A.; Bidaux, G.;
Dege ny, C.; Ve eman, K.; e al. TRP channel-associa ed ac o s a e a no el p o ein amily ha egula es
TRPM8 a icking and ac i i y. J. Cell Biol. 2015,208, 89–107. [C ossRe ] [PubMed]
23.
Villalobos, C.; Sob adillo, D.; He nandez-Mo ales, M.; Nunez, L. Calcium emodeling in colo ec al cance .
Biochim. Biophys. Ac a 2017,1864, 843–849. [C ossRe ] [PubMed]
24.
Cai, R.; Ding, X.; Zhou, K.; Shi, Y.; Ge, R.; Ren, G.; Jin, Y.; Wang, Y. Blockade o TRPC6 channels induced
G2/M phase a es and supp essed g ow h in human gas ic cance cells. In . J. Cance
2009
,125, 2281–2287.
[C ossRe ] [PubMed]

Cance s 2018,10, 331 17 o 18
25.
Thebaul , S.; Flou akis, M.; Vano e be ghe, K.; Vande moe e, F.; Roudba aki, M.; Lehen’kyi, V.; Slomianny, C.;
Beck, B.; Ma io , P.; Bonnal, J.L.; e al. Di e en ial ole o ansien ecep o po en ial channels in Ca
2+
en y
and p oli e a ion o p os a e cance epi helial cells. Cance Res. 2006,66, 2038–2047. [C ossRe ] [PubMed]
26.
Ding, X.; He, Z.; Zhou, K.; Cheng, J.; Yao, H.; Lu, D.; Cai, R.; Jin, Y.; Dong, B.; Xu, Y.; e al. Essen ial ole o
TRPC6 channels in G2/M phase ansi ion and de elopmen o human glioma. J. Na l. Cance Ins .
2010
,102,
1052–1068. [C ossRe ] [PubMed]
27.
El Bous any, C.; Bidaux, G.; En issi, A.; Delcou , P.; P e a skaya, N.; Capiod, T. Capaci a i e calcium en y
and ansien ecep o po en ial canonical 6 exp ession con ol human hepa oma cell p oli e a ion. Hepa ology
2008,47, 2068–2077. [C ossRe ] [PubMed]
28.
Xu, J.; Yang, Y.; Xie, R.; Liu, J.; Nie, X.; An, J.; Wen, G.; Liu, X.; Jin, H.; Tuo, B. The NCX1/TRPC6 complex
media es TGFbe a-d i en mig a ion and in asion o human hepa ocellula ca cinoma cells. Cance Res.
2018
,
78, 2564–2576. [C ossRe ] [PubMed]
29.
Dhennin-Du hille, I.; Gau ie , M.; Faouzi, M.; Guilbe , A.; B e e , M.; Vaud y, D.; Ahidouch, A.; Se es e, H.;
Ouadid-Ahidouch, H. High exp ession o ansien ecep o po en ial channels in human b eas cance
epi helial cells and issues: Co ela ion wi h pa hological pa ame e s. Cell Physiol. Biochem.
2011
,28, 813–822.
[C ossRe ] [PubMed]
30.
Ouadid-Ahidouch, H.; Dhennin-Du hille, I.; Gau ie , M.; Se es e, H.; Ahidouch, A. TRP calcium channel
and b eas cance : Exp ession, ole and co ela ion wi h clinical pa ame e s. Bull. Cance
2012
,99, 655–664.
[PubMed]
31.
Ayda , E.; Yeo, S.; Djamgoz, M.; Palme , C. Abno mal exp ession, localiza ion and in e ac ion o canonical
ansien ecep o po en ial ion channels in human b eas cance cell lines and issues: A po en ial a ge o
b eas cance diagnosis and he apy. Cance Cell In . 2009,9, 23. [C ossRe ] [PubMed]
32.
Ja din, I.; Diez-Bello, R.; Lopez, J.J.; Redondo, P.C.; Salido, G.M.; Smani, T.; Rosado, J.A.; Cellula Physiology
Resea ch G oup, Depa men o Physiology, Ins i u e o Molecula Pa hology Bioma ke s, Uni e si y o
Ex emadu a, Cace es, Spain; Depa men o Medical Physiology and Biophysic, Ins i u e o Biomedicine o
Se illa, Se illa, Spain. Unpublished wo k. 2018.
33.
Hammadi, M.; Chopin, V.; Ma i a , F.; Dhennin-Du hille, I.; Chasse aud, M.; Se es e, H.;
Ouadid-Ahidouch, H. Human e he a-gogo K(+) channel 1 (hEag1) egula es MDA-MB-231 b eas cance cell
mig a ion h ough O ai1-dependen calcium en y. J. Cell Physiol.
2012
,227, 3837–3846. [C ossRe ] [PubMed]
34.
Gueguinou, M.; Ha nois, T.; C o es, D.; Uguen, A.; Delio , N.; Gambade, A.; Chan ome, A.; Hael e s, J.P.;
Ja es, P.A.; Jou dan, M.L.; e al. SK3/TRPC1/O ai1 complex egula es SOCE-dependen colon cance cell
mig a ion: A no el oppo uni y o modula e an i-EGFR mAb ac ion by he alkyl-lipid Ohmline. Onco a ge
2016,7, 36168–36184. [C ossRe ] [PubMed]
35.
Mo iani, R.K.; Abdullae , I.F.; T ebak, M. A no el na i e s o e-ope a ed calcium channel encoded by O ai3:
Selec i e equi emen o O ai3 e sus O ai1 in es ogen ecep o -posi i e e sus es ogen ecep o -nega i e
b eas cance cells. J. Biol. Chem. 2010,285, 19173–19183. [C ossRe ] [PubMed]
36.
Mon ell, C.; Bi nbaume , L.; Flocke zi, V. The TRP channels, a ema kably unc ional amily. Cell
2002
,108,
595–598. [C ossRe ]
37.
Fliniaux, I.; Ge main, E.; Fa a iello, V.; P e a skaya, N. TRPs and Ca(
2+
) in cell dea h and su i al.
Cell Calcium. 2018,69, 4–18. [C ossRe ] [PubMed]
38.
Lee, W.H.; Choong, L.Y.; Jin, T.H.; Mon, N.N.; Chong, S.; Liew, C.S.; Pu i, T.; Lu, S.Y.; Ha eneck, C.;
Lim, Y.P. TRPV4 plays a ole in b eas cance cell mig a ion ia Ca(
2+
)-dependen ac i a ion o AKT and
down egula ion o E-cadhe in cell co ex p o ein. Oncogenesis 2017,6, e338. [C ossRe ] [PubMed]
39.
Lee, W.H.; Choong, L.Y.; Mon, N.N.; Lu, S.; Lin, Q.; Pang, B.; Yan, B.; K ishna, V.S.; Singh, H.; Tan, T.Z.;
e al. TRPV4 Regula es B eas Cance Cell Ex a asa ion, S i ness and Ac in Co ex. Sci. Rep.
2016
,6, 27903.
[C ossRe ] [PubMed]
40.
Meng, X.; Cai, C.; Wu, J.; Cai, S.; Ye, C.; Chen, H.; Yang, Z.; Zeng, H.; Shen, Q.; Zou, F. TRPM7 media es b eas
cance cell mig a ion and in asion h ough he MAPK pa hway. Cance Le .
2013
,333, 96–102. [C ossRe ]
[PubMed]
41.
Guilbe , A.; Gau ie , M.; Dhennin-Du hille, I.; Ha en, N.; Se es e, H.; Ouadid-Ahidouch, H. E idence ha
TRPM7 is equi ed o b eas cance cell p oli e a ion. Am. J. Physiol. Cell Physiol.
2009
,297, C493–C502.
[C ossRe ] [PubMed]
Cance s 2018,10, 331 18 o 18
42.
Jiang, Y.; Gou, H.; Zhu, J.; Tian, S.; Yu, L. Lidocaine inhibi s he in asion and mig a ion o TRPV6-exp essing
cance cells by TRPV6 down egula ion. Oncol. Le . 2016,12, 1164–1170. [C ossRe ] [PubMed]
43.
Guilbe , A.; Dhennin-Du hille, I.; Hiani, Y.E.; Ha en, N.; Kho si, H.; Se es e, H.; Ahidouch, A.;
Ouadid-Ahidouch, H. Exp ession o TRPC6 channels in human epi helial b eas cance cells. BMC Cance
2008,8, 125. [C ossRe ] [PubMed]
44.
Alba an, L.; Lopez, J.J.; Dionisio, N.; Smani, T.; Salido, G.M.; Rosado, J.A. T ansien ecep o po en ial
anky in-1 (TRPA1) modula es s o e-ope a ed Ca(
2+
) en y by egula ion o STIM1-O ai1 associa ion.
Biochim. Biophys. Ac a 2013,1833, 3025–3034. [C ossRe ] [PubMed]
45.
Schindl, R.; F i sch, R.; Ja din, I.; F ischau , I.; Kah , H.; Muik, M.; Riedl, M.C.; G oschne , K.; Romanin, C.
Canonical ansien ecep o po en ial (TRPC) 1 ac s as a nega i e egula o o anilloid TRPV6-media ed
Ca2+ in lux. J. Biol. Chem. 2012,287, 35612–35620. [C ossRe ] [PubMed]
46.
Lopez, E.; Be na-E o, A.; Salido, G.M.; Rosado, J.A.; Redondo, P.C. FKBP52 is in ol ed in he egula ion
o SOCE channels in he human pla ele s and MEG 01 cells. Biochim. Biophys. Ac a
2013
,1833, 652–662.
[C ossRe ] [PubMed]
47.
Dionisio, N.; Smani, T.; Wooda d, G.E.; Cas ellano, A.; Salido, G.M.; Rosado, J.A. Home p o eins media e
he in e ac ion be ween STIM1 and Ca 1.2 channels. Biochim. Biophys. Ac a
2015
,1853, 1145–1153. [C ossRe ]
[PubMed]
48.
Alba an, L.; Lopez, J.J.; Wooda d, G.E.; Salido, G.M.; Rosado, J.A. S o e-ope a ed Ca
2+
en y-associa ed
egula o y ac o (SARAF) plays an impo an ole in he egula ion o a achidona e- egula ed Ca
2+
(ARC)
channels. J. Biol. Chem. 2016,291, 6982–6988. [C ossRe ] [PubMed]
49.
Alba an, L.; Lopez, J.J.; Gomez, L.J.; Salido, G.M.; Rosado, J.A. SARAF modula es TRPC1, bu no TRPC6,
channel unc ion in a STIM1-independen manne . Biochem. J. 2016,473, 3581–3595. [C ossRe ] [PubMed]
50.
Zbidi, H.; Ja din, I.; Wooda d, G.E.; Lopez, J.J.; Be na-E o, A.; Salido, G.M.; Rosado, J.A. STIM1 and STIM2
A e Loca ed in he Acidic Ca
2+
S o es and Associa es wi h O ai1 upon Deple ion o he Acidic S o es in
Human Pla ele s. J. Biol. Chem. 2011,286, 12257–12270. [C ossRe ] [PubMed]
51.
Alba an, L.; Be na-E o, A.; Dionisio, N.; Redondo, P.C.; Lopez, E.; Lopez, J.J.; Salido, G.M.; B ull Saba e, J.M.;
Rosado, J.A. TRPC6 pa icipa es in he egula ion o cy osolic basal calcium concen a ion in mu ine es ing
pla ele s. Biochim. Biophys. Ac a 2014,1843, 789–796. [C ossRe ] [PubMed]
©
2018 by he au ho s. Licensee MDPI, Basel, Swi ze land. This a icle is an open access
a icle dis ibu ed unde he e ms and condi ions o he C ea i e Commons A ibu ion
(CC BY) license (h p://c ea i ecommons.o g/licenses/by/4.0/).